BACKGROUND:In the AZA-001 trial, azacitidine (75 mg/m2/d subcutaneously for Days 1-7 of every 28-day cycle) demonstrated improved survival compared with co... LR Silverman,P Fenaux,GJ Mufti,... - 《Cancer》 被引量: 451发表: 2011年 Phase 2 study of the lenalidomide and azacitidine co...